BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. IL1A, glucose metabolic process, Influenza, Kidney, Holistic medicine, Clofibrate)
Bookmark Forward

QuickView for dasatinib (compound)


Genetic Markers

Most Correlated Genes

  1. XIST
  2. CRIP1
  3. AGR2
  4. WIF1
  5. RBP4
Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

  1. cytosol
  2. PUJANA_BRCA1_PCC_NETWORK
  3. regulation of nitrogen compound metabolic process
  4. organic cyclic compound binding
  5. heterocyclic compound binding
Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

  1. Ovarian tumor biopsies from a Phase I dasatinib trial
  2. Chronic meylogenous leukemia K562 cells dasatinib treated: time course
  3. Rhabdomyosarcoma A-204 cells treated with dasatinib or pazopanib or sunitinib
  4. Prostate cancer mouse models treated with different compounds
  5. Chronic myeloid leukemia progenitor cells treated with imatinib, dasatinib, BMS214662 or BMS225975
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Dasatinib-induced colitis: clinical, endoscopic and histological findings.
  2. Multicomponent crystal compromising dasatinib and selected co-crystals formers: a patent evaluation …
  3. Low-dose Dasatinib Ameliorates Hypertrophic Cardiomyopathy in Noonan Syndrome with Multiple Lentigin…
  4. Resolution of dasatinib-associated lymphadenopathy following discontinuation of dasatinib in patient…
  5. A simple isotope-labeled UHPLC-MS/MS assay for simultaneous quantification of methotrexate, imatinib…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Dasatinib In Waldenström Macroglobulinemia
  2. Dasatinib in Polycythemia Vera
  3. Dasatinib Holiday for Improved Tolerability
  4. Trial of Dasatinib in Advanced Sarcomas
  5. Dasatinib and Crizotinib in Advanced Cancer
Explore Clinical Trials Results
  • Copyright © 2023 Illumina Inc. All rights reserved.